Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Waxman

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Cancer Research|August 10, 2013
Downregulation of microRNA-515-5p by the estrogen receptor modulates sphingosine kinase 1 and breast cancer cell proliferationFilipa G Pinho, Adam E Frampton, Joao Nunes, et al.
Oncology Reports|April 30, 2010
Kisspeptin is released from human prostate cancer cell lines but plasma kisspeptin is not elevated in patients with prostate cancerAnnette E Curtis, Kevin G Murphy, Owais B Chaudhri, et al.
Molecular & Cellular Proteomics : MCP|February 20, 2015
Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cellsGreg N Brooke, Simon C Gamble, Michael A Hough, et al.
The Journal of Pathology|November 11, 2011
TGFβ1-Endo180-dependent collagen deposition is dysregulated at the tumour-stromal interface in bone metastasisMatthew P Caley, Giolanta Kogianni, Adam Adamarek, et al.
The Journal of Pathology|November 20, 2014
AGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survivalMercedes Rodriguez-Teja, Julian H Gronau, Claudia Breit, et al.
EMBO Reports|February 17, 2016
miR-515-5p controls cancer cell migration through MARK4 regulationOlivier E Pardo, Leandro Castellano, Catriona E Munro, et al.
Cancer Research|December 21, 2010
FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growthGreg N Brooke, Rachel L Culley, D Alwyn Dart, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Cancer Research|August 10, 2013
Downregulation of microRNA-515-5p by the estrogen receptor modulates sphingosine kinase 1 and breast cancer cell proliferationFilipa G Pinho, Adam E Frampton, Joao Nunes, et al.
Oncology Reports|April 30, 2010
Kisspeptin is released from human prostate cancer cell lines but plasma kisspeptin is not elevated in patients with prostate cancerAnnette E Curtis, Kevin G Murphy, Owais B Chaudhri, et al.
Molecular & Cellular Proteomics : MCP|February 20, 2015
Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cellsGreg N Brooke, Simon C Gamble, Michael A Hough, et al.
The Journal of Pathology|November 11, 2011
TGFβ1-Endo180-dependent collagen deposition is dysregulated at the tumour-stromal interface in bone metastasisMatthew P Caley, Giolanta Kogianni, Adam Adamarek, et al.
The Journal of Pathology|November 20, 2014
AGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survivalMercedes Rodriguez-Teja, Julian H Gronau, Claudia Breit, et al.
EMBO Reports|February 17, 2016
miR-515-5p controls cancer cell migration through MARK4 regulationOlivier E Pardo, Leandro Castellano, Catriona E Munro, et al.
Cancer Research|December 21, 2010
FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growthGreg N Brooke, Rachel L Culley, D Alwyn Dart, et al.
Pageof 8